Experimental Ebola drug to become more widely available

The World Health Organization (WHO) said it would convene a meeting of medical ethics experts next week to consider the implications of making experimental Ebola drugs more widely available.

Read More

Portugal partners Nigeria to improve health, pharmaceuticals

Portugal has expressed its readiness to strengthen the trade ties with Nigeria, even as some Portuguese firms have concluded plans to leverage opportunities in the country and invest in the key sectors of the economy.

Read More

Roche to acquire biotech firm Seragon for $1.7bn‎

Roche Holding AG said it will pay up to $1.725 billion to buy Seragon Pharmaceuticals, a privately-held U.S. biotech company that researches breast cancer treatments, according to Reuters.

Read More

Endo International acquires Dava Pharmaceuticals for $600m

Endo International has announced its acquisition of generic drug producer Dava Pharmaceuticals for $600 million.

Read More

5 million Nigerians to join fight against fake drugs - SON

The Standard Organisation of Nigeria (SON) has said it would be involving 5 million Nigerians in the fight against fake drugs in the country. Dr. Joseph Odumodu, Director-General of the organisation said this while speaking in Ibadan, Oyo state at an enlightenment  tagged  “Zero  Tolerance Against Substandard Products.”

Read More

NAFDAC warns against high consumption of energy drinks

The regulatory agency in charge of foods and drugs control in Nigeria, the National Agency for Food and Drugs Administration and Control (NAFDAC) has enjoined Nigerians to be cautious when taking energy drinks because of associated health risks.

Read More

Amgen completes study on new anti-cholesterol drug

US publicly traded pharmaceutical company, Amgen Inc has announced it has completed a fifth late-stage study of its experimental anti-cholesterol medicine, leading competitors that are trying to bring a new class of therapies to a market estimated to be worth billions.

Read More

New drug approved for the treatment of Hepatitis C

The European Commission has approved the use of Gilead Sciences Inc's high-profile new hepatitis C drug Sovaldi  across the European Union.

Read More

Health expert calls for cheaper antimalaria drugs

Prof Egbert Kessi, head of Tanzania's Moshibased Kilimanjaro Christian Medical University College (KCMU College) has challenged researchers to develop cheap and affordable drugs to fight malaria as another effective strategy of eradicating the disease.

Read More

Organizers drive PharmaTech Africa 2014 dialogue forward with HealthNewsNG partnership

PharmaAfrica, organizers of PharmaTech Africa Exhibition and Conference have partnered with HealthNewsNG.com, Africa's leading online health news platform, with the goal of driving the dialogue forward.

Read More